{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:17:03Z","timestamp":1788916623936,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","ajconline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.amjcard.2024.07.011","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T04:56:53Z","timestamp":1721883413000},"page":"118-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Efficiency and Safety of Intracoronary Epinephrine Administration in Patients With ST-Elevation Myocardial Infarction With Refractory Coronary No-Reflow"],"prefix":"10.1016","volume":"226","author":[{"given":"Vyacheslav","family":"Ryabov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3692-5892","authenticated-orcid":false,"given":"Stanislav","family":"Dil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeny","family":"Vyshlov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Mochula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kercheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey","family":"Baev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egor","family":"Gergert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid","family":"Maslov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2024.07.011_bib0001","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2024.07.011_bib0002","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.jacc.2009.11.087","article-title":"Therapy for ST-segment elevation myocardial infarction patients who present late or are ineligible for reperfusion therapy","volume":"55","author":"Cohen","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2024.07.011_bib0003","doi-asserted-by":"crossref","first-page":"e11617","DOI":"10.1097\/MD.0000000000011617","article-title":"Clinical associations of microvascular obstruction and intramyocardial hemorrhage on cardiovascular magnetic resonance in patients with acute ST segment elevation myocardial infarction (STEMI): an observational cohort study","volume":"97","author":"Ma","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.amjcard.2024.07.011_bib0004","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jjcc.2014.03.008","article-title":"The \u201cno reflow\u201d phenomenon following acute myocardial infarction: mechanisms and treatment options","volume":"64","author":"Kaul","year":"2014","journal-title":"J Cardiol"},{"key":"10.1016\/j.amjcard.2024.07.011_bib0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1148\/radiol.2021204265","article-title":"Cardiac MRI to visualize myocardial damage after ST-segment elevation myocardial infarction: a review of its histologic validation","volume":"301","author":"Beijnink","year":"2021","journal-title":"Radiology"},{"key":"10.1016\/j.amjcard.2024.07.011_bib0006","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1161\/CIRCIMAGING.112.973222","article-title":"Characterizing myocardial edema and hemorrhage using quantitative T2 and T2* mapping at multiple time intervals post ST-segment elevation myocardial infarction","volume":"5","author":"Zia","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.amjcard.2024.07.011_bib0007","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1093\/eurheartj\/ehx414","article-title":"Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials","volume":"38","author":"de Waha","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2024.07.011_bib0008","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jcmg.2014.05.010","article-title":"Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients","volume":"7","author":"van Kranenburg","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.amjcard.2024.07.011_bib0009","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1093\/eurheartj\/ehx288","article-title":"The importance of no-reflow\/microvascular obstruction in the STEMI patient","volume":"38","author":"Kloner","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2024.07.011_bib0010","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/ehjci\/jey101","article-title":"Intramyocardial haemorrhage and prognosis after ST-elevation myocardial infarction","volume":"20","author":"Reinstadler","year":"2019","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.amjcard.2024.07.011_bib0011","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1093\/eurheartj\/eht100","article-title":"Magnetic resonance imaging-defined areas of microvascular obstruction after acute myocardial infarction represent microvascular destruction and haemorrhage","volume":"34","author":"Robbers","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2024.07.011_bib0012","doi-asserted-by":"crossref","first-page":"57","DOI":"10.29001\/2073-8552-2022-37-2-57-64","article-title":"Risk assessment score of no-reflow phenomenon in predicting myocardial perfusion disorders by contrast echocardiography in ST-segment elevation myocardial infarction patients after endovascular revascularization","volume":"37","author":"Bessonov","year":"2022","journal-title":"Siberian J Clin Exp Med"},{"key":"10.1016\/j.amjcard.2024.07.011_bib0013","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jcin.2016.11.059","article-title":"Management of no-reflow phenomenon in the catheterization laboratory","volume":"10","author":"Rezkalla","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2024.07.011_bib0014","first-page":"935","article-title":"Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations","volume":"38","author":"Hausenloy","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2024.07.011_bib0015","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3892\/etm.2013.1139","article-title":"Intracoronary fixed dose of nitroprusside via thrombus aspiration catheter for the prevention of the no-reflow phenomenon following primary percutaneous coronary intervention in acute myocardial infarction","volume":"6","author":"Zhao","year":"2013","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.amjcard.2024.07.011_bib0016","doi-asserted-by":"crossref","first-page":"14","DOI":"10.29001\/2073-8552-2023-39-2-14-22","article-title":"Reperfusion cardiac injury: the role of microvascular obstruction","volume":"38","author":"Derkachev","year":"2023","journal-title":"Sib J Clin Exp Med"},{"key":"10.1016\/j.amjcard.2024.07.011_bib0017","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/ccd.29113","article-title":"Efficacy and safety of intracoronary epinephrine versus conventional treatments alone in STEMI patients with refractory coronary no-reflow during primary PCI: the RESTORE observational study","volume":"97","author":"Navarese","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2024.07.011_bib0018","doi-asserted-by":"crossref","first-page":"34","DOI":"10.18087\/cardio.2024.6.n2493","article-title":"Intracoronary administration of epinephrine in the refractory no-reflow phenomenon in patients with acute myocardial infarction","volume":"64","author":"Vyshlov","year":"2024","journal-title":"Kardiologiia"},{"key":"10.1016\/j.amjcard.2024.07.011_bib0019","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.15829\/1728-8800-2022-2936","article-title":"Intracoronary epinephrine and verapamil in the refractory no-reflow phenomenon in patients with acute myocardial infarction","volume":"21","author":"Dil","year":"2022","journal-title":"Cardiovasc Ther Prev"},{"key":"10.1016\/j.amjcard.2024.07.011_bib0020","first-page":"1086","article-title":"American Society of Echocardiography. American Society of Echocardiography recommendations for use of echocardiography in clinical trials","volume":"17","author":"Gottdiener","year":"2004","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.amjcard.2024.07.011_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198144","article-title":"Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease","volume":"13","author":"Ramchand","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.amjcard.2024.07.011_bib0022","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJMoa1208200","article-title":"Door-to-balloon time and mortality among patients undergoing primary PCI","volume":"369","author":"Menees","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2024.07.011_bib0023","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.121.011408","article-title":"Comparison of intracoronary epinephrine and adenosine for no-reflow in normotensive patients with acute coronary syndrome (COAR trial)","volume":"15","author":"Khan","year":"2022","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2024.07.011_bib0024","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/joic.12318","article-title":"Efficacy and safety of local intracoronary drug delivery in treatment of no-reflow phenomenon: a pilot study","volume":"29","author":"Abu Arab","year":"2016","journal-title":"J Interv Cardiol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914924005423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914924005423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T15:58:52Z","timestamp":1723823932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914924005423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":24,"alternative-id":["S0002914924005423"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2024.07.011","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficiency and Safety of Intracoronary Epinephrine Administration in Patients With ST-Elevation Myocardial Infarction With Refractory Coronary No-Reflow","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2024.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}